NASDAQ:KIDS

OrthoPediatrics (KIDS) Stock Forecast, Price & News

$32.53

+0.16 (+0.49%)

(As of 10:30 AM ET)

Compare

Today's Range: $32.22
▼
$32.66
50-Day Range: $32.37
▼
$44.97
52-Week Range: $31.88
▼
$53.50

Volume: 7,293 shs
Average Volume: 100,877 shs
Market Capitalization: $759.58 million

P/E Ratio: 361.44
Dividend Yield: N/A
Price Target: $53.60

OrthoPediatrics MarketRank™ Forecast

Analyst Rating: Buy
3.00 Rating Score
Upside/Downside: 65.7% Upside
$53.60 Price Target
Short Interest: Bearish
8.34% of Float Sold Short
Dividend Strength: N/A
Sustainability: -1.20
Upright™ Environmental Score
News Sentiment: 0.77
Based on 2 Articles This Week
Insider Trading: Selling Shares
$290,146 Sold Last Quarter
Proj. Earnings Growth: Growing
From ($0.97) to ($0.88) Per Share

Overall MarketRank^™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.30 out of 5 stars

Medical Sector

282nd out of 965 stocks

Surgical & Medical Instruments Industry

39th out of 94 stocks

3.5

Analyst's Opinion

Consensus Rating
OrthoPediatrics has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 4 buy ratings, no hold ratings, and no sell ratings.
Price Target Upside/Downside
According to analysts' consensus price target of $53.60, OrthoPediatrics has a forecasted upside of 65.7% from its current price of $32.35.
Amount of Analyst Coverage
OrthoPediatrics has only been the subject of 3 research reports in the past 90 days.

0.0

Short Interest

Percentage of Shares Shorted
8.34% of the float of OrthoPediatrics has been sold short.
Short Interest Ratio / Days to Cover
OrthoPediatrics has a short interest ratio ("days to cover") of 15.4, which indicates bearish sentiment.
Change versus previous month
Short interest in OrthoPediatrics has recently increased by 4.80%, indicating that investor sentiment is decreasing.

0.0

Dividend Strength

Dividend Yield
OrthoPediatrics does not currently pay a dividend.
Dividend Growth
OrthoPediatrics does not have a long track record of dividend growth.

3.9

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
OrthoPediatrics has received a 52.35% net impact score from Upright. The largest positive contribution comes from its "Physical diseases" impact, which is mostly driven by its "Synthetic bone grafts", "Cervical implants", and "Medical screws" products. See details.
Environmental Sustainability
The Environmental Impact score for OrthoPediatrics is -1.20.

3.2

News and Social Media Coverage

News Sentiment
OrthoPediatrics has a news sentiment score of 0.77. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.54 average news sentiment score of Medical companies.
News Coverage This Week
MarketBeat has tracked 2 news articles for OrthoPediatrics this week, compared to 1 article on an average week.
Search Interest
1 people have searched for KIDS on MarketBeat in the last 30 days.

4.2

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, OrthoPediatrics insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $290,146.00 in company stock.
Percentage Held by Insiders
32.60% of the stock of OrthoPediatrics is held by insiders. A high percentage of insider ownership can be a sign of company health.
Percentage Held by Institutions
68.36% of the stock of OrthoPediatrics is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

0.6

Earnings and Valuation

Earnings Growth
Earnings for OrthoPediatrics are expected to grow in the coming year, from ($0.97) to ($0.88) per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of OrthoPediatrics is 359.44, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 117.64.
Price to Earnings Ratio vs. Sector
The P/E ratio of OrthoPediatrics is 359.44, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 96.30.
Price to Book Value per Share Ratio
OrthoPediatrics has a P/B Ratio of 1.96. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

About OrthoPediatrics (NASDAQ:KIDS) Stock

OrthoPediatrics Corp., a medical device company, designs, develops, and markets anatomically appropriate implants and devices for the treatment of children with orthopedic conditions in the United States and internationally. The company offers trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products. Its products comprise PediLoc, PediPlates, cannulated screws, PediFlex nail, PediNail, PediLoc tibia, anterior cruciate ligament reconstruction systems, locking cannulated blades, locking proximal femurs, Spica Tables, RESPONSE Spine systems, Bandloc, Pediguard, Pediatric Nailing Platform, Femur system, Orthex, QuickPack, and ApiFix Mid-C system. The company serves pediatric orthopedic market, as well as pediatric orthopedic surgeons and caregivers. OrthoPediatrics Corp. was founded in 2006 and is headquartered in Warsaw, Indiana.

KIDS Price History

30 days | 90 days | 365 days | Advanced Chart

KIDS Stock News Headlines

September 17, 2023 | americanbankingnews.com

OrthoPediatrics Corp. (NASDAQ:KIDS) Given Average Recommendation of "Buy" by Brokerages

September 14, 2023 | finance.yahoo.com

OrthoPediatrics Corp. to Participate at the Gilmartin Group Emerging Growth Company Showcase

September 22, 2023 | Chaikin Analytics (Ad)

Buy This Stock for AI Tidal Wave (not NVDA)

The internet boom made more millionaires than any tech - Microsoft’s CEO says AI has even more potential. Here’s the #1 stock to buy.

September 11, 2023 | msn.com

OrthoPedatrics gets FDA clearance for pediatric tibia platform

September 11, 2023 | finance.yahoo.com

OrthoPediatrics Corp. Receives FDA 510(k) Clearance for Pediatric Nailing Platform | Tibia

September 1, 2023 | markets.businessinsider.com

4 Analysts Have This to Say About OrthoPediatrics

September 1, 2023 | markets.businessinsider.com

JMP Securities Remains a Buy on OrthoPediatrics (KIDS)

August 29, 2023 | fool.com

OrthoPediatrics (NASDAQ: KIDS)

September 22, 2023 | Chaikin Analytics (Ad)

Buy This Stock for AI Tidal Wave (not NVDA)

The internet boom made more millionaires than any tech - Microsoft’s CEO says AI has even more potential. Here’s the #1 stock to buy.

August 14, 2023 | benzinga.com

OrthoPediatrics Insider Trades Send a Signal

August 2, 2023 | msn.com

JMP Securities Reiterates OrthoPediatrics (KIDS) Market Outperform Recommendation

August 1, 2023 | msn.com

Needham Reiterates OrthoPediatrics (KIDS) Buy Recommendation

August 1, 2023 | finance.yahoo.com

Compared to Estimates, OrthoPediatrics (KIDS) Q2 Earnings: A Look at Key Metrics

July 31, 2023 | finance.yahoo.com

OrthoPediatrics Corp. Reports Second Quarter 2023 Financial Results

July 24, 2023 | markets.businessinsider.com

OrthoPediatrics (KIDS) Receives a Buy from Truist Financial

July 18, 2023 | finance.yahoo.com

OrthoPediatrics Corp. to Report Second Quarter 2023 Financial Results on August 1, 2023

July 17, 2023 | markets.businessinsider.com

Analysts Offer Insights on Healthcare Companies: Inspire Medical Systems (INSP), UnitedHealth (UNH) and OrthoPediatrics (KIDS)

June 27, 2023 | benzinga.com

COO and CFO of OrthoPediatrics Sold $190K In Stock

June 27, 2023 | finance.yahoo.com

OrthoPediatrics Corp. Announces the Launch and First Case Using the GIRO™ Growth Modulation System

June 15, 2023 | finance.yahoo.com

OrthoPediatrics Announces Election of George Dyer, MD to its Board of Directors

May 30, 2023 | finance.yahoo.com

With OrthoPediatrics Corp. (NASDAQ:KIDS) It Looks Like You'll Get What You Pay For

May 23, 2023 | markets.businessinsider.com

OrthoPediatrics (KIDS) Gets a Buy from JMP Securities

May 4, 2023 | finance.yahoo.com

OrthoPediatrics Corp. Announce Launch of RESPONSE™ Power Scoliosis System

May 1, 2023 | finance.yahoo.com

OrthoPediatrics Corp. Reports First Quarter 2023 Financial Results and Increases Full Year 2023 Revenue Guidance

May 1, 2023 | finance.yahoo.com

OrthoPediatrics Corp. Continues Leading Sponsorship at 2023 POSNA Annual Meeting

April 20, 2023 | finance.yahoo.com

OrthoPediatrics Corp. Announces Launch of RESPONSE™ 5.5/6.0 Cannulated Screw System

April 19, 2023 | finance.yahoo.com

Investors in OrthoPediatrics (NASDAQ:KIDS) have made a strong return of 158% over the past five years

See More Headlines

Receive KIDS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for OrthoPediatrics and its competitors with MarketBeat's FREE daily newsletter.

KIDS Company Calendar

Last Earnings: 7/31/2023
Today: 9/22/2023
Next Earnings (Estimated): 10/30/2023
Fiscal Year End: 12/31/2023

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Surgical & medical instruments
Sub-Industry: N/A
Sector: Medical
Current Symbol: NASDAQ:KIDS
CUSIP: N/A
CIK: 1425450
Web: www.orthopediatrics.com
Phone: (574) 268-6379
Fax: 574-269-3692
Employees: 203
Year Founded: N/A

Price Target and Rating

Average Stock Price Forecast: $53.60
High Stock Price Forecast: $60.00
Low Stock Price Forecast: $50.00
Forecasted Upside/Downside: +65.6%
Consensus Rating: Buy
Rating Score (0-4): 3.00
Research Coverage: 4 Analysts

Profitability

EPS (Most Recent Fiscal Year): $0.09
Trailing P/E Ratio: 359.67
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $1.26 million
Net Margins: 0.73%
Pretax Margin: -3.04%
Return on Equity: -5.03%
Return on Assets: -4.43%

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: 5.04
Quick Ratio: 2.99

Sales & Book Value

Annual Sales: $122.29 million
Price / Sales: 6.18
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: $16.54 per share
Price / Book: 1.96

Miscellaneous

Outstanding Shares: 23,350,000
Free Float: 15,739,000
Market Cap: $755.84 million
Optionable: Not Optionable
Beta: 0.85

7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed Investors

As the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.

Get This Free Report

Key Executives

Mr. Mark C. Throdahl (Age 72)
Exec. Chairman

Mr. David R. Bailey (Age 44)
Pres, CEO & Director
Comp: $588.47k

Mr. Fred L. Hite (Age 55)
CFO, Principal Financial & Accounting Officer, COO and Director
Comp: $578.75k

Mr. Daniel J. Gerritzen (Age 53)
Exec. VP of Legal & Gen. Counsel
Comp: $470.44k

Mr. Gregory A. Odle (Age 53)
Pres of Scoliosis
Comp: $484.32k

Mr. Kevin L. Unger CHE (Age 51)
MBA/MSHA, Pres of Enabling Technologies
Comp: $56.25k

Mr. Joseph W. Hauser (Age 41)
Pres of Trauma & Deformity Correction
Comp: $470.44k

Mr. Joel Batts
Sr. VP of Clinical & Regulatory Affairs

Mr. Mark Karshner
Sr. VP of International Sales

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions

KIDS Stock - Frequently Asked Questions

Should I buy or sell OrthoPediatrics stock right now?: 4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for OrthoPediatrics in the last twelve months. There are currently 4 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" KIDS shares.
View KIDS analyst ratings or view top-rated stocks.
What is OrthoPediatrics' stock price forecast for 2023?: 4 Wall Street analysts have issued 1-year price targets for OrthoPediatrics' shares. Their KIDS share price forecasts range from $50.00 to $60.00. On average, they anticipate the company's stock price to reach $53.60 in the next twelve months. This suggests a possible upside of 65.6% from the stock's current price.
View analysts price targets for KIDS or view top-rated stocks among Wall Street analysts.
How have KIDS shares performed in 2023?: OrthoPediatrics' stock was trading at $39.73 at the beginning of the year. Since then, KIDS stock has decreased by 18.5% and is now trading at $32.37.
View the best growth stocks for 2023 here.
When is OrthoPediatrics' next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Monday, October 30th 2023.
View our KIDS earnings forecast.
How were OrthoPediatrics' earnings last quarter?: OrthoPediatrics Corp. (NASDAQ:KIDS) posted its earnings results on Monday, July, 31st. The company reported ($0.19) EPS for the quarter, hitting the consensus estimate of ($0.19). The business had revenue of $39.56 million for the quarter, compared to the consensus estimate of $39.11 million. OrthoPediatrics had a net margin of 0.73% and a negative trailing twelve-month return on equity of 5.03%.
What guidance has OrthoPediatrics issued on next quarter's earnings?: OrthoPediatrics updated its FY 2023 earnings guidance on Tuesday, August, 1st. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $148.00 million-$151.00 million, compared to the consensus revenue estimate of $149.28 million.
What is Mark Throdahl's approval rating as OrthoPediatrics' CEO?: 15 employees have rated OrthoPediatrics Chief Executive Officer Mark Throdahl on Glassdoor.com. Mark Throdahl has an approval rating of 100% among the company's employees. This puts Mark Throdahl in the top 10% of approval ratings compared to other CEOs of publicly-traded companies.
What other stocks do shareholders of OrthoPediatrics own?: Based on aggregate information from My MarketBeat watchlists, some companies that other OrthoPediatrics investors own include AbbVie (ABBV), Freeport-McMoRan (FCX), Gilead Sciences (GILD), Intel (INTC), Advanced Micro Devices (AMD), CRISPR Therapeutics (CRSP), Cisco Systems (CSCO), Walt Disney (DIS), Enterprise Products Partners (EPD) and NVIDIA (NVDA).

When did OrthoPediatrics IPO?: (KIDS) raised $52 million in an initial public offering (IPO) on Thursday, October 12th 2017. The company issued 4,000,000 shares at a price of $12.00-$14.00 per share. Piper and Jaffray Stifel acted as the underwriters for the IPO and William Blair and BTIG were co-managers.
What is OrthoPediatrics' stock symbol?: OrthoPediatrics trades on the NASDAQ under the ticker symbol "KIDS."
Who are OrthoPediatrics' major shareholders?: OrthoPediatrics' stock is owned by many different retail and institutional investors. Top institutional shareholders include Brown Capital Management LLC (15.02%), Brown Advisory Inc. (6.88%), BlackRock Inc. (4.70%), Riverbridge Partners LLC (4.67%), Braidwell LP (3.26%) and Granahan Investment Management LLC (2.14%). Insiders that own company stock include (Reynolds) Marie C Infante, Bernie B Berry III, Bernie B Berry III, Daniel J Gerritzen, David R Bailey, David R Pelizzon, Fred Hite, Gregory A Odle, Harold Ruf, Jennifer N Pritzker, Joseph W Hauser, Mark C Throdahl, Stephen F Burns and Terry D Schlotterback.
View institutional ownership trends.
How do I buy shares of OrthoPediatrics?: Shares of KIDS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.
What is OrthoPediatrics' stock price today?: One share of KIDS stock can currently be purchased for approximately $32.37.
How much money does OrthoPediatrics make?: OrthoPediatrics (NASDAQ:KIDS) has a market capitalization of $755.84 million and generates $122.29 million in revenue each year. The company earns $1.26 million in net income (profit) each year or $0.09 on an earnings per share basis.
How many employees does OrthoPediatrics have?: The company employs 203 workers across the globe.
How can I contact OrthoPediatrics?: OrthoPediatrics' mailing address is 2850 Frontier Drive, Warsaw IN, 46582. The official website for the company is www.orthopediatrics.com. The company can be reached via phone at (574) 268-6379, via email at tbui@theruthgroup.com, or via fax at 574-269-3692.

This page (NASDAQ:KIDS) was last updated on 9/22/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial